Healx Limited: against COVID-19 Company
Entity: Healx
Category: AI for Drug Discovery
Description: Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments.
Project: Healx using artificial intelligence to find combination drug treatments for COVID-19.
Summary: Healx’s AI is being used to discover drug combinations to target the virus and improve immune response to COVID-19. Healx is using its powerful AI platform to support vulnerable rare disease patients by applying drug repurposing expertise to target COVID-19. Combination therapy candidates will be available for external testing in collaboration with partners.
Category: AI for Drug Discovery
Description: Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments.
Project: Healx using artificial intelligence to find combination drug treatments for COVID-19.
Summary: Healx’s AI is being used to discover drug combinations to target the virus and improve immune response to COVID-19. Healx is using its powerful AI platform to support vulnerable rare disease patients by applying drug repurposing expertise to target COVID-19. Combination therapy candidates will be available for external testing in collaboration with partners.
Connections from
Technology:
AI for Drug Discovery
Headquarters:
United Kingdom
Founded Date:
1905
Employees Number:
11-50
Funding Status:
Early Stage Venture
Register and Claim Ownership